- Home
- HQL
as 11-21-2024 10:35am EST
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.
| Founded: | 1992 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 391.1M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 120.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.79 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.34 - $14.37 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest abrdn Life Sciences Investors Shares of Beneficial Interest News
HQL Breaking Stock News: Dive into HQL Ticker-Specific Updates for Smart Investing
ACCESSWIRE
10 days ago
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
ACCESSWIRE
2 months ago
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
ACCESSWIRE
3 months ago
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
ACCESSWIRE
5 months ago
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
ACCESSWIRE
5 months ago
abrdn Life Sciences Investors (HQL) Announces Results of Annual Meeting of Shareholders
Business Wire
5 months ago
Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition
GlobeNewswire
5 months ago
Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus
GlobeNewswire
5 months ago
Share buy-back programme - week 23
Compare HQL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HQL abrdn Life Sciences Investors Shares of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.